Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$655M |
| 2 |
Coty
COTY
|
+$380M |
| 3 |
ConocoPhillips
COP
|
+$250M |
| 4 |
Zimmer Biomet
ZBH
|
+$213M |
| 5 |
Valero Energy
VLO
|
+$170M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$523M |
| 2 |
Merck
MRK
|
+$375M |
| 3 |
SHPG
Shire pic
SHPG
|
+$362M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$310M |
| 5 |
CELG
Celgene Corp
CELG
|
+$286M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.57% |
| 2 | Technology | 12.05% |
| 3 | Financials | 10.74% |
| 4 | Consumer Discretionary | 9.44% |
| 5 | Energy | 8.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
Abeona Therapeutics
ABEO
$355M
| $9.35M | 0.01% |
50,789
+10,570
| +26% | +$1.89M |
|
|
HA
1302
DELISTED
Hawaiian Holdings, Inc.
HA
| $9.33M | 0.01% |
355,290
+330,875
| +1,355% | +$9.61M |
|
1303
Adient
ADNT
$1.45B
| $9.32M | 0.01% |
719,135
-25,800
| -3% | -$452K |
|
|
GLOG
1304
DELISTED
GASLOG LTD
GLOG
| $9.31M | 0.01% |
533,475
-75,487
| -12% | -$1.31M |
|
1305
CDW
CDW
$17B
| $9.31M | 0.01% |
96,639
-546,646
| -85% | -$48.8M |
|
|
DPLO
1306
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $9.31M | 0.01% |
1,602,920
+928,980
| +138% | +$9.59M |
|
1307
Southern Copper
SCCO
$182B
| $9.28M | 0.01% |
255,226
-458,106
| -64% | -$14.5M |
|
1308
E.W. Scripps
SSP
$305M
| $9.28M | 0.01% |
441,712
-49,346
| -10% | -$981K |
|
|
PRSP
1309
DELISTED
Perspecta Inc. Common Stock
PRSP
| $9.22M | 0.01% |
455,941
+103,953
| +30% | +$2.09M |
|
1310
Ternium
TX
$10.8B
| $9.21M | 0.01% |
338,537
-35,467
| -9% | -$1.03M |
|
1311
Applied Materials
AMAT
$385B
| $9.21M | 0.01% |
232,329
-1,504,292
| -87% | -$57.1M |
|
1312
ACI Worldwide
ACIW
$5.23B
| $9.2M | 0.01% |
279,880
-117,018
| -29% | -$3.57M |
|
1313
Columbia Banking Systems
COLB
$8.65B
| $9.15M | 0.01% |
279,950
+262,342
| +1,490% | +$9.53M |
|
1314
T-Mobile US
TMUS
$195B
| $9.14M | 0.01% |
132,284
+8,987
| +7% | +$629K |
|
|
KYNB
1315
Kyntra Bio
KYNB
$32.6M
| $9.1M | 0.01% |
6,695
+6,467
| +2,836% | +$8.77M |
|
|
RARX
1316
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $9.09M | 0.01% |
405,940
-6,126
| -1% | -$132K |
|
|
NAV
1317
DELISTED
Navistar International
NAV
| $9.08M | 0.01% |
+281,093
| New | +$9.34M |
|
1318
Dine Brands
DIN
$449M
| $9.05M | 0.01% |
99,193
+64,971
| +190% | +$5.52M |
|
1319
ICF International
ICFI
$1.58B
| $9.05M | 0.01% |
119,001
+95,094
| +398% | +$6.71M |
|
1320
CALL
EOG Resources
EOG
$78.1B
| $9.05M | 0.01% |
95,100
| – | – |
|
|
HEXO
1321
DELISTED
HEXO Corp. Common Shares
HEXO
| $9.05M | 0.01% |
+24,376
| New | +$7.89M |
|
|
CBM
1322
DELISTED
Cambrex Corporation
CBM
| $9.04M | 0.01% |
232,812
+225,648
| +3,150% | +$9.24M |
|
|
HPP
1323
Hudson Pacific Properties
HPP
$812M
| $9.04M | 0.01% |
37,518
+3,089
| +9% | +$702K |
|
1324
Ultrapar
UGP
$7.05B
| $9.03M | 0.01% |
1,510,686
+494,292
| +49% | +$3.51M |
|
1325
CALL
RTX Corp
RTX
$282B
| $9.02M | 0.01% |
111,230
| – | – |
|
Similar funds
Israel Englander's Q1 2019 Portfolio in Review
As of Q1 2019, Israel Englander held 4,608 positions worth $66.8B, up 4.2% from $64.1B the previous quarter. Its ten largest holdings account for 7.1% of the portfolio.
Israel Englander withdrew a net $6.14B in Q1 2019, closing 675 positions and reducing 1,467 holdings. Its most notable exit was Merck, an estimated $375M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 14% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Zimmer Biomet worth $232M.
- Israel Englander's largest Q1 2019 buy was Zimmer Biomet: 1,870,503 shares worth $232M.
- Israel Englander added most to Walt Disney in Q1 2019, an estimated $655M increase.
- Israel Englander's biggest Q1 2019 reduction was Apple, cutting an estimated $523M.
- Israel Englander fully exited Merck in Q1 2019, selling an estimated $375M.
- Israel Englander's ten largest holdings make up 7.1% of its $66.8B portfolio in Q1 2019.
- Israel Englander opened 914 new positions and closed 675 in Q1 2019.
- Israel Englander's portfolio value rose 4.2% quarter-over-quarter to $66.8B.
Based on Millennium Management's 13F filing for Q1 2019, filed 14 May 2019.